Abstract
We report the case of a child who developed severe obstructive hypertrophic cardiomyopathy revealing hereditary tyrosinaemia type I, who was successfully treated with NTBC. The mechanisms underlying the association are discussed.
MeSH terms
-
Amino Acid Metabolism, Inborn Errors / drug therapy
-
Cardiomyopathy, Hypertrophic / therapy*
-
Cyclohexanones / pharmacology*
-
Echocardiography
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Hypertrophy, Left Ventricular
-
Infant
-
Male
-
Nitrobenzoates / pharmacology*
-
Tyrosine / blood
-
Tyrosinemias / drug therapy*
Substances
-
Cyclohexanones
-
Enzyme Inhibitors
-
Nitrobenzoates
-
Tyrosine
-
nitisinone